Almirall, S.A. (FRA:E2Z)

Market Cap	2.32B
Revenue (ttm)	1.05B
Net Income (ttm)	21.34M
Shares Out	n/a
EPS (ttm)	0.10
PE Ratio	108.72
Forward PE	31.39
Dividend	0.15 (1.43%)
Ex-Dividend Date	May 15, 2025

Volume	1,650
Average Volume	288
Open	10.28
Previous Close	10.22
Day's Range	10.28 - 10.48
52-Week Range	8.09 - 11.28
Beta	n/a
RSI	55.70
Earnings Date	Jul 25, 2025

About Almirall

Almirall, S.A. operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa. The company offers its products for skin diseases comprising Psoriasis, atopic dermatitis, acne, actinic keratosis, onychomycosis, androgenic alopecia, oncodermatology, and orphan indications, as well as for alimentary tract and metabolism; antiinfectives for systemic use; cardiovascular, musculo-skeletal, nervous, and respiratory system; dermatologicals; genito urinary system and sex hormones; immun...

• Industry: Pharmaceutical Preparations
• Founded: 1943
• Employees: 2,026
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: E2Z